A report written by The Economist Intelligence Unit, and sponsored by Pfizer and the International Alliance of Dermatology Patient Organizations (GlobalSkin). It considers the healthcare system approaches and policy responses to the management of atopic dermatitis (AD), often referred to as atopic eczema